$396,843
+6.1%
DIR; Director SURG PATH and Cytology Bidmc
2024
$340k related
55 hrs/wk
$58k other
--
DIR; Director SURG PATH and Cytology Bidmc at Bih Pathology Foundation Inc.
Fiscal year ended September 30, 2024. Published on January 25, 2026.
Total compensation
Vanderlaan M.D. Ph.D. Paul has been listed as an employee of Bih Pathology Foundation Inc. in Form 990 filings since fiscal year 2022. Total compensation for Vanderlaan M.D. Ph.D. Paul has increased by 23.5% from 2022 to 2024.